Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved Bizengri for adults with advanced NRG1 fusion-positive cholangiocarcinoma, marking the first approved treatment for the rare bile duct cancer …
FDA Approves Bizengri for Rare Bile Duct Cancer Read More
PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) reported additional Phase 2 trial data showing a dose-response relationship for its SkinJect treatment candidate for nodular basal cell carcinoma, with the …
Medicus Pharma Reports Expanded Phase 2 Skin Cancer Trial Data Read More
PLYMOUTH MEETING, PA — National Comprehensive Cancer Network released a new patient guide on prostate cancer screening aimed at explaining current screening recommendations and addressing concerns about testing and treatment.
NCCN Releases Patient Guide on Prostate Cancer Screening Read More
WASHINGTON, D.C. — Federal regulators have cleared the way for certain pancreatic cancer patients to access an experimental drug earlier than usual, approving a rapid pathway that allows treatment outside …
FDA Fast-Tracks Access to Experimental Pancreatic Drug Read More
WILMINGTON, DE — AstraZeneca (Nasdaq: AZN) announced a national public health campaign encouraging Americans to speak with their doctors about cancer risk and screening, partnering with actor Joshua Jackson and …
AstraZeneca Launches Cancer Screening Campaign With Joshua Jackson Read More
HARRISBURG, PA — Pennsylvania health and insurance officials are urging residents to get screened earlier for colorectal cancer, citing rising cases among younger adults and emphasizing that most screenings are …
Pa. Officials Urge Early Cancer Screenings Amid Rising Cases Read More
WILMINGTON, DE — The U.S. Food and Drug Administration has accepted and granted Priority Review to a supplemental application for ENHERTU, a breast cancer treatment developed by AstraZeneca and Daiichi …
FDA Grants Priority Review to ENHERTU for Early Breast Cancer Use Read More
PLYMOUTH MEETING, PA — A nationwide clinical trial found that cancer patients who followed a structured exercise program during chemotherapy reported fewer problems with thinking and memory, according to research …
Study Finds Exercise May Reduce Cognitive Effects During Chemotherapy Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network announced it has published new NCCN Clinical Practice Guidelines in Oncology for Pediatric Soft Tissue Sarcomas, expanding its library of cancer …
NCCN Releases Pediatric Soft Tissue Sarcoma Guidelines Read More PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network, on World Cancer Day, observed February 4, highlighted its free patient guidelines aimed at helping people navigate a cancer diagnosis, according …
NCCN Highlights Free Patient Cancer Guidelines on World Cancer Day Read More